A detailed history of American Portfolios Advisors transactions in Horizon Therapeutics Public LTD CO stock. As of the latest transaction made, American Portfolios Advisors holds 25,790 shares of HZNP stock, worth $0. This represents 0.07% of its overall portfolio holdings.

Number of Shares
25,790
Holding current value
$0
% of portfolio
0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$58.92 - $84.67 $1.52 Million - $2.18 Million
25,790 New
25,790 $1.6 Billion
Q2 2022

Mar 20, 2023

BUY
$79.4 - $116.36 $87,340 - $127,996
1,100 Added 4.27%
26,890 $2.14 Billion
Q1 2022

Mar 21, 2023

BUY
$86.42 - $109.81 $155,901 - $198,097
1,804 Added 6.99%
27,594 $2.9 Billion
Q4 2021

Mar 21, 2023

SELL
$98.56 - $119.91 $321,305 - $390,906
-3,260 Reduced 12.64%
22,530 $2.43 Billion
Q3 2021

Mar 22, 2023

SELL
$91.91 - $110.37 $423,337 - $508,364
-4,606 Reduced 17.86%
21,184 $2.32 Billion
Q2 2021

Mar 22, 2023

SELL
$86.24 - $95.92 $439,824 - $489,192
-5,100 Reduced 19.78%
20,690 $1.94 Billion
Q1 2021

Mar 22, 2023

SELL
$71.83 - $95.48 $376,101 - $499,933
-5,236 Reduced 20.3%
20,554 $1.89 Billion
Q4 2020

Mar 22, 2023

SELL
$67.0 - $84.39 $377,545 - $475,537
-5,635 Reduced 21.85%
20,155 $1.47 Billion
Q3 2020

Mar 22, 2023

SELL
$55.23 - $79.93 $311,662 - $451,044
-5,643 Reduced 21.88%
20,147 $1.57 Billion
Q2 2020

Mar 24, 2023

BUY
$30.2 - $56.98 $80,422 - $151,737
2,663 Added 15.28%
20,094 $1.12 Billion
Q1 2020

Mar 24, 2023

SELL
$24.87 - $38.56 $207,888 - $322,323
-8,359 Reduced 32.41%
17,431 $516 Million
Q4 2019

Mar 24, 2023

SELL
$25.43 - $36.67 $207,381 - $299,043
-8,155 Reduced 31.62%
17,635 $638 Million
Q3 2019

Mar 24, 2023

SELL
$23.0 - $27.97 $17,618 - $21,425
-766 Reduced 4.1%
17,909 $488 Million
Q2 2019

Mar 24, 2023

SELL
$22.81 - $28.48 $162,293 - $202,635
-7,115 Reduced 27.59%
18,675 $449 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.